The overexpression of E2F7 in HCC tissue and cells was only reported in the study of Yu-Shui Ma et al. that can activate AKT 1-cyclin D1 signaling and the downstream cell cycle [20]. Here, E2F7 is linked to hepatocellular carcinoma.